HighVista Strategies »

Bridgebio Oncology Therapeut shares owned by HighVista Strategies

Quarter-by-quarter ownership of Bridgebio Oncology Therapeut (BBOT) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Bridgebio Oncology Therapeut

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Oncology Therapeut held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Oncology Therapeut by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.9M 229k 12.52

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Structure Therapeutics Sponsored Ads (GPCR)
Cogent Biosciences (COGT)
Miragen Therapeutics (VRDN)
Abivax Sa Sponsored Ads (ABVX)
Revolution Medicines (RVMD)
Praxis Precision Medicines I Com New (PRAX)
Nuvalent Inc-a (NUVL)
Cytokinetics Com New (CYTK)
Terns Pharmaceuticals (TERN)
Maze Therapeatics (MAZE)
Insmed Com Par $.01 (INSM)
Apogee Therapeutics (APGE)
Protagonist Therapeutics (PTGX)
Soleno Therapeutics (SLNO)

View all positions for HighVista Strategies

Top funds holding Bridgebio Oncology Therapeut

Cormorant Asset Management
Deerfield Management Company
Omega Fund Management
Wellington Management Company
EcoR1 Capital
Alphabet
Enavate Sciences GP
Citadel Advisors
Novo A/S
BlackRock
Laurion Capital Management
Adage Capital Partners GP
Armistice Capital
Eventide Asset Management
Aisling Capital Management

View all funds holding Bridgebio Oncology Therapeut